Slide

Poxel Announces Completion of Arbitration with Merck Serono

Poxel SA, a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH), today announced the completion of its arbitration with Merck Serono.